Topical tacrolimus in the treatment of atopic dermatitis--does it benefit the airways? A 4-year open follow-up.
Virtanen
Hannele
H
Remitz
Anita
A
Malmberg
Pekka
P
Rytilä
Paula
P
Metso
Tuula
T
Haahtela
Tari
T
Reitamo
Sakari
S
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000818:Animals; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology*; D016535:Bronchial Hyperreactivity / Q000503:physiopathology; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D011446:Prospective Studies; D016559:Tacrolimus / Q000008:administration & dosage* / Q000009:adverse effects
D007166:Immunosuppressive Agents; D016559:Tacrolimus